BANK OF AMERICA CORP /DE/ - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 122 filers reported holding OCULAR THERAPEUTIX INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.9%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$179,187
-63.5%
57,066
-40.0%
0.00%
Q2 2023$490,737
+39.4%
95,104
+42.4%
0.00%
Q1 2023$351,936
+27.8%
66,781
-31.9%
0.00%
Q4 2022$275,408
+14.8%
98,010
+68.9%
0.00%
Q3 2022$240,000
+51.9%
58,035
+47.6%
0.00%
Q2 2022$158,000
-35.8%
39,311
-20.7%
0.00%
Q1 2022$246,000
-57.5%
49,571
-40.4%
0.00%
Q4 2021$579,000
+10.1%
83,107
+57.9%
0.00%
Q3 2021$526,000
+2.9%
52,644
+46.1%
0.00%
Q2 2021$511,000
-41.0%
36,038
-31.7%
0.00%
Q1 2021$866,000
-29.8%
52,789
-11.4%
0.00%
Q4 2020$1,233,000
+25.9%
59,573
-53.7%
0.00%
Q3 2020$979,000
+37.5%
128,738
+50.4%
0.00%
Q2 2020$712,000
+947.1%
85,579
+516.3%
0.00%
Q1 2020$68,000
-5.6%
13,887
-23.1%
0.00%
Q4 2019$72,000
+35.8%
18,057
+1.3%
0.00%
Q3 2019$53,000
+3.9%
17,818
+50.3%
0.00%
Q2 2019$51,000
+13.3%
11,854
+3.8%
0.00%
Q1 2019$45,000
-57.1%
11,419
-56.5%
0.00%
Q4 2018$105,000
+72.1%
26,271
+197.0%
0.00%
Q3 2018$61,000
+45.2%
8,846
+42.0%
0.00%
Q2 2018$42,000
+200.0%
6,231
+175.8%
0.00%
Q1 2018$14,000
+16.7%
2,259
-15.6%
0.00%
Q4 2017$12,000
+71.4%
2,678
+133.9%
0.00%
Q3 2017$7,000
-86.3%
1,145
-79.3%
0.00%
Q2 2017$51,000
-29.2%
5,527
-29.0%
0.00%
Q1 2017$72,000
+7.5%
7,782
-2.8%
0.00%
Q4 2016$67,000
+81.1%
8,009
+49.2%
0.00%
Q3 2016$37,000
+85.0%
5,369
+36.8%
0.00%
Q2 2016$20,000
+66.7%
3,926
+227.2%
0.00%
Q1 2016$12,000
-70.7%
1,200
-72.3%
0.00%
Q4 2015$41,000
+583.3%
4,333
+967.2%
0.00%
Q3 2015$6,000
-82.9%
406
-75.5%
0.00%
Q2 2015$35,000
+3400.0%
1,660
+7117.4%
0.00%
Q1 2015$1,000230.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q2 2022
NameSharesValueWeighting ↓
SUMMER ROAD LLC 3,804,788$15,105,00043.34%
Versant Venture Management, LLC 2,215,384$8,795,074,0002.90%
Opaleye Management Inc. 1,900,000$7,543,0002.09%
SV Health Investors, LLC 628,236$2,494,0001.46%
Endurant Capital Management LP 716,124$2,843,0001.12%
DELTEC ASSET MANAGEMENT LLC 824,747$3,274,0000.72%
NOTTINGHAM ADVISORS, INC. 146,946$583,0000.08%
Jump Trading, LLC 39,255$156,0000.05%
Man Group plc 1,723,456$6,842,0000.03%
JGP Global Gestao de Recursos Ltda. 13,880$55,0000.02%
View complete list of OCULAR THERAPEUTIX INC shareholders